MET inhibition did not result in marked loss of ERK1/2 phosphorylation in either GNAQ or wild-type cells, thus the growth inhibiting effect of METi treatment in GNAQ mutant uveal melanoma cells may be mediated through a distinctly different signaling pathway. The gene discussed is MAPK3; the disease is uveal melanoma.